Amgen to release Q1 2026 earnings on April 30 with a live investor call.

Amgen announced it will report its first quarter 2026 financial results on April 30, 2026, after U.S. markets close. The company will hold a live conference call with investors at 4:30 p.m. ET, featuring CEO Robert A. Bradway and senior management. The webcast will be accessible on Amgen's website and archived for 90 days. This event is important for investors to assess Amgen's ongoing innovation and financial health in the biotech sector.